Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®
Completed · NCT05904210
Conditions: Hemophilia
At a glance
- Research payments reported, 2025
- $53,575
- U.S. investigators named
- 8
- Sites paid
- 8
- Planned or actual enrollment
- 17
About the trial
- Sponsor
- Laboratoire français de Fractionnement et de Biotechnologies
- Tested
- SEVENFACT® (drug)
- Dates
- Started 2023-11-07; completion 2024-05-09
- Results posted
- Not yet
Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT® \[coagulation factor VIIa (recombinant)-jncw\] in the USA. The current study will provide a unique opportunity to describe the profile of the early patients selected for treatment with SEVENFACT® and to assess the real-world utilization (effectiveness, safety, tolerability, and modalities of treatment) of SEVENFACT®.
From ClinicalTrials.gov, last updated 2024-06-25. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Hema Biologics, LLC reported $53,575 in research payments for this study in 2025 (16 payments).
Products named: Sevenfact
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Vinod V. Balasa, M.D. Pediatric Hematology & Oncology · Madera, CA
- Doris Quon, M.D. Hematology · Los Angeles, CA
- Sanjay P. Ahuja, MD Pediatric Hematology & Oncology · Indianapolis, IN
- Michael M. White, M.D. Internal Medicine · Farmington Hills, MI
- Ahmad Al-huniti, M.D Pediatric Hematology & Oncology · Rochester, MN
- Andrea M. Dvorak, M.D. Pediatric Hematology & Oncology · Syracuse, NY
- Adam Cuker, MD Hematology · Philadelphia, PA
- Miguel A. Escobar, M.D. Hematology · Houston, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- University Hospitals Cleveland Medical Center $11,900
- $10,350
- Mayo Clinic $7,500
- Penn Medicine $6,750
- Valley Children's Hospital, CA $5,675
- Children's Healthcare of Atlanta Inc $5,500
- Suny Upstate Medical University $3,100
- Orthopaedic Institute for Childrenorthopaedic Hemophilia Treatment Center $1,500
- The University of Texas Health Science Center at Houston $1,300
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.